Evidence map›Paper›PMID 38576718›Full record

ArticleRSC chemical biology2024

Tracking the cellular uptake and phototoxicity of Ru(ii)-polypyridyl-1,8-naphthalimide Tröger's base conjugates.

Sandra A Bright, MariaLuisa Erby, Fergus E Poynton, Daniel Monteyne, David Pérez-Morga, Thorfinnur Gunnlaugsson, D Clive Williams, Robert B P Elmes

Open access · goldAbstract read
In one paragraph

Article in RSC chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sandra A BrightSchool of Biochemistry and Immunology, Biomedical Sciences Institute, Trinity College Dublin 2 Ireland clive.williams@tcd.ie +353 1 8962596.
MariaLuisa ErbySchool of Biochemistry and Immunology, Biomedical Sciences Institute, Trinity College Dublin 2 Ireland clive.williams@tcd.ie +353 1 8962596.
Fergus E PoyntonSchool of Chemistry, Centre for Synthesis and Chemical Biology, Biomedical Sciences Institute, Trinity College Dublin Dublin 2 Ireland gunnlaut@tcd.ie +353 1 8963459.
Daniel MonteyneLaboratoire de Parasitologie Moléculaire, IBMM-DBM Université Libre de Bruxelles Gosselies Belgium.
David Pérez-MorgaLaboratoire de Parasitologie Moléculaire, IBMM-DBM Université Libre de Bruxelles Gosselies Belgium.
Thorfinnur GunnlaugssonSchool of Chemistry, Centre for Synthesis and Chemical Biology, Biomedical Sciences Institute, Trinity College Dublin Dublin 2 Ireland gunnlaut@tcd.ie +353 1 8963459.ORCID https://orcid.org/0000-0003-4814-6853
D Clive WilliamsSchool of Biochemistry and Immunology, Biomedical Sciences Institute, Trinity College Dublin 2 Ireland clive.williams@tcd.ie +353 1 8962596.
Robert B P ElmesSynthesis and Solid State Pharmaceutical Centre (SSPC), University of Limerick Ireland.ORCID https://orcid.org/0000-0001-7898-903X
Trinity College Dublin · IEUniversité Libre de Bruxelles · BENational University of Ireland, Maynooth · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ruthenium(ii) complexes are attracting significant research attention as a promising class of photosensitizers (PSs) in photodynamic therapy (PDT). Having previously reported the synthesis of two novel Ru(ii)-polypyridyl-1,8-naphthalimide Tröger's base compounds 1 and 2 with interesting photophysical properties, where the emission from either the Ru(ii) polypyridyl centres or the naphthalimide moieties could be used to monitor binding to nucleic acids, we sought to use these compounds to investigate further and in more detail their biological profiling, which included unravelling their mechanism of cellular uptake, cellular trafficking and cellular responses to photoexcitation. Here we demonstrate that these compounds undergo rapid time dependent uptake in HeLa cells that involved energy dependent, caveolae and lipid raft-dependent mediated endocytosis, as demonstrated by confocal imaging, and transmission and scanning electron microscopy. Following endocytosis, both compounds were shown to localise to mostly lysosomal and Golgi apparatus compartments with some accumulation in mitochondria but no localisation was found to the nucleus. Upon photoactivation, the compounds increased ROS production and induced ROS-dependent apoptotic cell death. The photo-activated compounds subsequently induced DNA damage and altered tubulin, but not actin structures, which was likely to be an indirect effect of ROS production and induced apoptosis. Furthermore, by changing the concentration of the compounds or the laser used to illuminate the cells, the mechanism of cell death could be changed from apoptosis to necrosis. This is the first detailed biological study of Ru(ii)-polypyridyl Tröger's bases and clearly suggests caveolae-dependent endocytosis is responsible for cell uptake - this may also explain the lack of nuclear uptake for these compounds and similar results observed for other Ru(ii)-polypyridyl complexes. These conjugates are potential candidates for further development as PDT agents and may also be useful in mechanistic studies on cell uptake and trafficking.

Identifiers

PMID38576718
PMCPMC10989513
OpenAlexW4392006694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.